Ocugen downgraded by Cantor Fitzgerald with a new price target

5/7/21 12:00:11 PM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Cantor Fitzgerald downgraded Ocugen from Overweight to Neutral and set a new price target of $11.00 from $15.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$OCGN

Date	Price Target	Rating	Analyst
10/15/2024	$4.00	Buy	Maxim Group
3/1/2023	$3.50	Neutral → Buy	Chardan Capital Markets
8/23/2022	$5.00	Buy	Mizuho
6/15/2022	$8.00	Buy	ROTH Capital
6/2/2022	$4.50	Overweight	Cantor Fitzgerald
2/28/2022	$10.00 → $8.00	Buy	HC Wainwright & Co.
7/26/2021		Outperform	Noble Capital Markets